Tasfoods Limited · ASX:TFL

Tasfoods — H1 2025 Earnings Presentation

14 slides from Tasfoods's earnings presentation, Aug 29, 2025

  1. Slide 1: H1 2025 Results Presentation

    TasFoods Ltd (TFL.ASX) H1 2025 Results Presentation H1 2025 Results Presentation | August 2025

  2. Slide 2: H1 2025 Highlights

    H1 2025 Highlights

  3. Slide 3: Significant actions delivered on our Path Forward in extremely challenging market conditions

    Significant actions delivered on our Path Forward in extremely challenging market conditions TasFoods has become a streamlined and simplified business • This has assisted the Company to best navigate the challenging market dynamics from FY2024 and into H1 2025, particularly in the Tasmanian poultry

  4. Slide 4: H1 2025 Financial Results Overview

    H1 2025 Financial Results Overview • Total Group operating EBITDA loss of $1.5m, a $0.5m (51%) increased loss on previous year (H1 2024: $1m loss); • Statutory Group Net Profit After Tax (NPAT) loss of $3.6m which includes a non-cash impairment of $1.2m of Poultry property, plant and equipment (PP&E

  5. Slide 5: H1 2025 Financial Highlights: Operating EBITDA (Continued and Discontinued Operations)

    H1 2025 Financial Highlights: Operating EBITDA (Continued and Discontinued Operations) H1 2025 Continued operations Discontinued operations Consolidated • Operating EBITDA loss of $1.5m for the consolidated Shared operations was a 51% decline on prior corresponding Dairy Poultry Total Dairy Horticul

  6. Slide 6: H1 2025 Financial Results

    H1 2025 Financial Results

  7. Slide 7: Profit and loss – Consolidated Group (Continued and Discontinued Operations)

    Profit and loss – Consolidated Group (Continued and Discontinued Operations) Profit or Loss ($000’s) H1 2025 H1 2024 Income Total Consolidated Revenue 19,876 23,985 • Consolidated NPAT loss of $3.6m (continued and discontinued operations), inclusive of a $1.2m non-cash impairment of Nichols Other in

  8. Slide 8: Balance sheet

    Balance sheet $000's H1 2025 FY2024 Current Assets Cash & Cash Equivalents 55 485 Trade & Other Receivables 2,151 2,005 Biological Assets 2,991 2,805 • The Group is supported by a balance sheet with a net asset Inventory Assets classified as held for sale 2,015 1,597 2,232 1,597 position of $3.6m (n

  9. Slide 9: Cash flow

    Cash flow $000's H1 2025 H1 2024 Cash flows from operating activities Receipts from customers 19,830 24,161 • Net cash outflows from operating activities were $2.1m Payments to suppliers and employees (21,666) (25,245) (continued and discontinued operations), H1 2024: $1.7m Interest paid (182) (113)

  10. Slide 10: Outlook

    Outlook

  11. Slide 11: Outlook

    Outlook • We are observing Q3 2025 a continuation from FY2024 and YTD 2025 of the prolonged surplus of mainland chicken and increased competition through all market channels in Tasmania. This was particularly exacerbated by competitors heavily discounting poultry volumes at the wholesale and consume

  12. Slide 12: Outlook – Path Forward

    Outlook – Path Forward We are razor focused on building a more robust and stable business • Our immediate priorities are: o Strengthening the Poultry Supply Chain: Progressing initiatives to strengthen our poultry grower network, improving supply reliability and building on our relationships to impr

  13. Slide 13: Important notice and disclaimer

    This presentation is provided by TasFoods Ltd ACN 084 800 902 (TasFoods) to provide summary information about TasFoods and its subsidiaries and their activities as at the date of this presentation. The information in this presentation is of a general nature and does not purport to be complete and ma

  14. Slide 14: Contact

    Contact Joshua Fletcher | CEO E: joshua.fletcher@tasfoods.com.au

TasFoods — H1 2025 Earnings Presentation on 6ix